|
|
 |
|
Total Number of Holdings (excluding cash): 50
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
973 |
$80,720.08 |
2.39% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
751 |
$80,439.61 |
2.38% |
| Teleflex Incorporated |
TFX |
879369106 |
511 |
$80,278.10 |
2.37% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
2,623 |
$78,890.85 |
2.33% |
| Steris Plc |
STE |
G8473T100 |
298 |
$78,049.18 |
2.31% |
| LivaNova Plc |
LIVN |
G5509L101 |
837 |
$77,372.28 |
2.29% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
592 |
$76,242.09 |
2.26% |
| Becton, Dickinson and Company |
BDX |
075887109 |
348 |
$75,331.56 |
2.23% |
| Align Technology, Inc. |
ALGN |
016255101 |
448 |
$74,359.04 |
2.20% |
| Medtronic Plc |
MDT |
G5960L103 |
723 |
$74,382.24 |
2.20% |
| Alcon Inc. |
ALC.SW |
H01301128 |
1,001 |
$73,495.31 |
2.17% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
980 |
$73,021.11 |
2.16% |
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
175 |
$73,115.00 |
2.16% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
4,739 |
$72,801.73 |
2.15% |
| The Cooper Companies, Inc. |
COO |
216648501 |
1,176 |
$72,770.88 |
2.15% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
718 |
$72,812.38 |
2.15% |
| Cochlear Limited |
COH.AU |
Q25953102 |
714 |
$72,022.16 |
2.13% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
5,434 |
$71,874.03 |
2.13% |
| Stryker Corporation |
SYK |
863667101 |
231 |
$71,776.32 |
2.12% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
41 |
$70,817.66 |
2.09% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
1,460 |
$70,297.55 |
2.08% |
| BioMerieux |
BIM.FP |
F1149Y232 |
687 |
$69,337.67 |
2.05% |
| Abbott Laboratories |
ABT |
002824100 |
642 |
$68,982.90 |
2.04% |
| Insulet Corporation |
PODD |
45784P101 |
473 |
$68,722.17 |
2.03% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
201 |
$68,704.25 |
2.03% |
| Terumo Corporation |
4543.JP |
J83173104 |
4,460 |
$68,132.73 |
2.02% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
1,762 |
$67,184.58 |
1.99% |
| Baxter International Inc. |
BAX |
071813109 |
2,627 |
$67,093.58 |
1.98% |
| Danaher Corporation |
DHR |
235851102 |
291 |
$66,903.81 |
1.98% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
97 |
$67,059.01 |
1.98% |
| Waters Corporation |
WAT |
941848103 |
147 |
$66,652.74 |
1.97% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
151 |
$66,100.25 |
1.96% |
| ResMed Inc. |
RMD |
761152107 |
278 |
$66,216.82 |
1.96% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
268 |
$65,887.70 |
1.95% |
| Boston Scientific Corporation |
BSX |
101137107 |
1,497 |
$65,403.93 |
1.93% |
| Agilent Technologies, Inc. |
A |
00846U101 |
375 |
$64,845.00 |
1.92% |
| Penumbra, Inc. |
PEN |
70975L107 |
200 |
$64,124.00 |
1.90% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,251 |
$64,025.27 |
1.89% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
2,392 |
$63,720.29 |
1.88% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
175 |
$63,045.50 |
1.87% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
733 |
$63,294.55 |
1.87% |
| DexCom, Inc. |
DXCM |
252131107 |
760 |
$62,023.60 |
1.83% |
| Revvity, Inc. |
RVTY |
714046109 |
415 |
$61,772.75 |
1.83% |
| LeMaitre Vascular, Inc. |
LMAT |
525558201 |
793 |
$61,068.93 |
1.81% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
857 |
$60,418.50 |
1.79% |
| Hoya Corporation |
7741.JP |
J22848105 |
394 |
$57,157.34 |
1.69% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
2,377 |
$56,750.35 |
1.68% |
| Olympus Corporation |
7733.JP |
J61240107 |
5,040 |
$55,923.05 |
1.65% |
| Shanghai Microport Medbot (Group) Co., Ltd. (Class H) |
2252.HK |
Y768JD106 |
16,500 |
$44,540.04 |
1.32% |
| US Dollar |
$USD |
|
22,978 |
$22,977.72 |
0.68% |
| Japanese Yen |
$JPY |
|
237,600 |
$1,490.31 |
0.04% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.15 |
0.00% |
| TPG Inc. (CVR) |
2602335D |
436CVR021 |
612 |
$0.00 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|